We then quantified the amount of IL-17A protein in the BAL fluid and found that there was a numeric trend towards higher IL-17A in patients with VAP, however that difference was not statistically significant (p = 0.07, Fig 2C). This evidence concerns the gene IL17A and ventilator-associated pneumonia.